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ABSTRACT
OBJECTIVE: To study the epidemiology of methicillin-
resistant Staphylococcus aureus (MRSA) over a prolonged
period of time with the aid of a molecular typing method
(ribotyping).
SETTING: A 1,000-bed tertiary university medical
center.
PATIENTS AND METHODS: Defined epidemiol-
ogical data were recorded for all patients culture-positive for
MRSA between 1989 and 1992. Ribotyping of MRSA strains
was performed using three restriction enzymes: EcoRv,
HindHI, and KpnI.
RESULTS: From 1989 to 1992, MRSA was isolated
from clinical specimens in 98 patients and from surveillance
cultures in 27 patients. Among the 122 isolates available for
typing, 26 different ribotypes were identified. In 20% of the
cases, MRSA was community-acquired, and a third of these
patients never had been hospitalized previously. Nine
ribotypes were responsible for more than one case (2 to 64
patients); 17 appeared only once. Epidemiological data
correlated with ribotyping results revealed 14 epidemiologic
clusters involving six different ribotypes, whereas only three
outbreaks were suspected initially. The median follow-up
after the last isolation of a given ribotype was 14 months
(range, 1 to 42) for clusters and 25 months (range, 1 to 46)
for ribotypes that appeared only once. During clusters, only
16% of the cases occurred after the implementation of
control measures in the ward (breakthrough cases).
CONCLUSIONS: The high diversity of MRSA
strains observed over 4 years suggested that new strains
were introduced continuously in our hospital. Furthermore,
that 17 ribotypes were isolated only once, that breakthrough
cases represented only 16% of the cases in clusters, and that
the follow-up duration after the last isolation of a given
ribotyp  was more than 14 months suggest that infection
control measures were effective in limiting the nosocomial
spread of MRSA over a prolonged period of time (Infect
Control Hasp Epidemiol1995;16:260-267).
I N T R O D U C T I O N
Methicillin-resistant S aphylococcus aureus
(MRSA) strains are an important cause of nosocomial
infection and are difficult to control once they have
been introduced in an institution.’ Therefore, it is of
utmost importance to improve our knowledge on the
epidemiology and control of MRSA.
Recently, molecular techniques have allowed
more refined epidemiological studies, and some have
been applied to MRSA.2-14 However, they have been
used mostly for the investigation of epidemic situa-
tions and over a limited period of time. To our
knowledge, only one study used such a typing method
to nalyze the epidemiology of MRSA in a given
hospital and over a prolonged period of time.4 The
method used was the DNA analysis of plasmid mark-
ers. However, plasmids may not always be present,
and there is evidence that they can be gained or lost
by b cteria over time.14 In this study, we used ribotyp-
i g, as it can be used with many bacteria, including
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MRSA, and has been proven to be discriminative and
useful for epidemiological purposes.7,412,14 The pur-
pose of the present study was to use this method to
investigate the epidemiology of MRSA in our hospital
over a 4-year period.
MATERIAL AND METHODS
Institutional Characteristics and Study Period
The University Hospital of Lausanne (Centre
hospitalier universitaire vaudois, CHUV) is a 1,000-
bed, tertiary-care, teaching hospital. The hospital has
40 intensivecare beds and approximately 30,000 admis-
sions per year. It serves a population of approximately
300,000.
From January 1989 to December 1992, all patients
with clinical or surveillance cultures positive for MRSA
were included in the study.
Microbiology
MRSA was identified by standard methods.
Except for five patients who harbored MRSA for a
long period of time, only the first isolate of each
patient was selected for further work-up. Susceptibil-
ity testing was performed by disk diffusion on Mueller-
Hinton agar with a 24-hour incubation at 35°C. An
inhibition diameter of less than 13 mm was considered
indicative of resistance to methicillin.15 Resistance
was confirmed by growing the isolates on Mueller-
Hinton agar supplemented with NaCl (40 g/L) and
oxacillin (6 mg/L).15 Surveillance cultures were inocu-
lated onto blood agar and Mueller-Hinton agar supple-
mented with NaCl and oxacillin.15
Ribotyping
Ribotyping was performed as previously
described.13 Briefly, cells were lysed by lysostaphin,
and DNA was extracted with phenol-chloroform.
Approximately 1 kg of DNA was digested with a
restriction enzyme (RE), and fragments were sepa-
rated by horizontal agarose gel electrophoresis. DNA
then was transferred to a nylon membrane, and
hybridization was performed with biotinylated plas-
mid pKK3535 containing an rRNA operon of E coli.‘~,i~
Hybrids were revealed on the membrane using a
nonradioactive nucleic acid detection system. For
each restrictive enzyme, the DNA fingerprint of each
isolate was scored visually for the presence and the
position of bands. Similarity between isolates was
evaluated by the presence or absence of bands using
the mismatch coefficient.17 The construction of a
dendrogram from the similarity data was performed
using the unweighted pair group method of analysis
(UPGMA).17 The discriminatory power of the typing
method was evaluated by the index of discrimination
(D) proposed by Gaston and Hunter.18
Epidemiology
For each patient, the following data were col-
lected: demographic data, geographic origin, date of
admission and discharge, location and transfer in the
hospital, previous admissions, diagnosis, bacteriologi-
cal results, and infection control measures.
Cases were defined as epidemiologically related
if they were present on the same nursing unit during
the same period as another patient colonized or
infected with the same ribotype and if no epidemiol-
ogical link could be found with patients of other units
(eg, common staff or transfer of cases). Cases without
epidemiological link were considered sporadic. MRSA
was considered community-acquired if isolated less
tha  48 hours after admission, provided that no
patient with MRSA was present in the same unit.
Breakthrough MRSA cases were defined as patients
initially negative for MRSA (documented by surveil-
lance cultures performed because MRSA cases were
identified in the same unit) but who became positive
on subsequent cultures, despite the implementation of
control measures. In other words, breakthrough cases
were nosocomial cases of acquisition of MRSA despite
the implementation of control measures. A pseu-
docluster was defined as a temporary increase in the
number of patients with MRSA (suggesting a cluster),
but with isolates that belonged to different ribotypes.
Infection Control Strategies
Patients with MRSA were identified by daily
rveillance of microbiological laboratory data and by
surveillance cultures of readmitted patients known to
have been positive for MRSA. Surveillance cultures
also were obtained from patients who had been
roommates of patients who were infected or colonized
w th MRSA. When a cluster was suspected, relevant
staff and their patients also were screened. Cultures
were obtained of the following sites: anterior nares,
axillary and inguinal areas, and infected sites or open
wounds.
Patients with MRSA were placed on strict isola-
tion: single room with gloves, gown, and masks for
staff and visitors. Daily control measures were imple-
mented for a minimum of 7 days and included total
body wash with chlorhexidine, intranasal application
of antimicrobials three times a day (bacitracin oint-
men  in 1989 and mupirocin since 1990), and systemic
oral ntibiotic (co-trimoxazole [320 mg:1200 mg/dayl
and rifampicin I600 mg/day], if the strain was sensi-
tive). Patients with clinically relevant infection were
treat  with vancomycin (duration according to clini-
cal situation). Isolation was discontinued when sur-
veillance cultures were negative on two occasions, the
f rst being obtained at least 2 days after the end of
treatment. If cultures still were positive, the same
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treatment was repeated once. If the patient still was
harboring MRSA after the second treatment, isolation
and local antimicrobial treatment were maintained
until discharge. Upon readmission, patients known to
have carried MRSA were isolated until results of
surveillance cultures were available.
RESULTS
Population
From 1989 to 1992, 1,000 to 1,200 patients had a
positive culture for S aureus each year. MRSA was
isolated from 4.2% of these patients in 1989, 3.9% in
1990, 1.8% in 1991, and 2.2% in 1992. Overall, 125
patients were colonized or infected with MRSA (107
hospitalized patients and 18 outpatients). Among
these, 98 (78%) were identified by clinical specimens
and 27 (22%) by surveillance cultures (890 samples in
202 patients). Positive specimens were wounds, 38%;
anterior nares, 23%; inguinas, 7%; axilla, 1%; urine, 11%;
sputum, 3%; oropharyngeal, 6%; and miscellaneous,
11%. At the time of the first isolation of MRSA, the
location of the patients was medical wards, 25%;
surgical wards, 25%; dermatology ward, 16%; ear-nose-
throat (ENT) ward, 8%; burn unit, 6%; intensive care
units, 4%; pediatric ward, 4%; and outpatient clinics,
12%. None were intravenous (IV) drug abusers.
Among the 125 patients, there were 25 cases (20%)
of deep infection that required vancomycin treatment
and 100 cases (80%) of superficial infection or coloniza-
tion. Deep infections were surgical wound infection, 6
cases; pneumonia, 5; super-infected pressure sore or leg
ulcer, 5; bacteremia, 3; urinary tract infection, 2;
abscesses, 2; peritonitis, 1; and empyema, 1.
Ribotyping
To select restriction enzymes that would give the
highest discrimination between isolates, ribotyping
initially was performed on 20 isolates that were
epidemiologically unrelated (either because they orig-
inated from different geographic areas around the
world or because they had been isolated <48 hours
after the first admission of patients with no link to
other known MRSA carriers in the hospital or else-
where). Fifteen restriction enzymes were tested: ApaI,
BamHI, CfoI, CIaI, DraI, EcoRI, EcoRV, HaeI, HindIII,
KpnI, PstI, SfuI, SmaI, XbaI, and XhoI. Three enzymes,
EcoRV, HindIII, and KpnI, gave the greatest number
of types when their restriction patterns were com-
bined. Therefore, DNA of all isolates were digested
with these three enzymes.
The reproducibility of ribotyping was evaluated
by testing 20 isolates several times at different peri-
ods. Identical banding patterns (relative position and
intensity of bands) were observed for each isolate and
with all restriction enzymes. The discriminatory power
of ribotyping for MRSA was evaluated by the index of
discrimination proposed by Gaston and Hunter.ls This
index was calculated from the data obtained from 40
unrelated strainslg and was found to be 0.954.
During the study period, most isolates of MRSA
were cryopreserved. Among the 125 patients, 122 had
at least one isolate available for ribotyping. Among
these 122 isolates, 20 different ribotyping patterns
were obtained with EcoRv; 17 with HindIII; and 23
with KpnI. Isolates were considered to belong to the
same ribotype when they shared the same patterns for
all three REs. On this basis, the 122 isolates were
distributed into 32 different ribotypes. For five patients
harboring MRSA for a long period of time (range, 6 to
12.5 months; median 7.6 months), several isolates
wer  typed. Three patients were constantly colonized
with the same ribotype; for the remaining two patients,
the last isolate differed by only one band position from
previous isolates. These minor changes observed in
ribotype most likely were due to a genetic change of
the strain. Therefore, for epidemiological purposes,
isolates that differed by no more than one band for the
three RE were considered similar (Figure 1). Thus,
the 122 MRSA isolates were grouped into 26 main
ribotypes (Figure 2). Nine ribotypes included isolates
from more than one patient, whereas 17 ribotypes
were found in only one patient each.
Epidemiology
The monthly incidence of affected patients accord-
ing to their ribotype is shown in Figure 3. Epidemiol-
ogical data correlated with ribotyping results disclosed
14 epidemiologic clusters involving 6 different
ribotypes, whereas only three outbreaks were sus-
pected initially. Ribotype 1 accounted for seven clus-
ters (2 to 17 patients, total 47 patients). The two
largest clusters concerned the dermatologic ward (17
patients) and ENT ward (9 patients). These two wards
were located on two wings of the same floor, but
hospital staff were different, and the outbreaks were
separated by 1 year. Ribotype 1 also was isolated from
15 additional patients, who were considered sporadic
cases. Ribotype 8 was isolated only in a burn unit
outbreak. Four other ribotypes (Nos. 10, 13, 16, and
17) were found in five other clusters (2 to 6 patients),
as well as in 8 sporadic cases. All other ribotypes were
found in sporadic cases. All strains obtained from
patients identified by surveillance culture belonged to
the nine ribotypes responsible for clusters.
Overall, epidemiological links eventually could
be found for 80 (66%) of 122 patients, whereas 42
(34%) of 122 were considered sporadic cases. Ribotyp-
ng llowed us to recategorize as pseudoclusters four
groups of cases that had been suspected to be clusters
on the basis of increased MRSA incidence (April and
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EcoRV
- 48.5 kb
- 18.5
- 7.4
lb 16 18 la
FIGURE 1. Example of EcoRV rRNA patterns of MRSA. A one-band
difference can be observed between ribotypes la and lb. A similar
difference is observed between ribotypes 16 and 18, but these two
ribotypes differed also by two bands with the restriction enzyme
Kpnl, whereas ribotypes la and lb had similar pattern with HinDlll
and Kpnl (data not shown).
November 1989, January and November 1992). In fact,
4 to 5 different ribotypes were involved in each of
these pseudoclusters (Figure 3).
Among the 97 nosocomial cases, 24 were from a
ribotype observed for the first time in the hospital and
were considered index cases. MRSA was considered
community-acquired in 25 cases (20%). Among these,
17 (68%) came from the geographical area served by
the hospital and 8 (32%) came from foreign countries.
Of these 25 patients, 9 (36%) had never been hospital-
ized before and one came from a nursing home.
Control of MRSA
The complete set of control measures was applied
to 83% of the 107 hospitalized patients, whereas 11%
had isolation measures only and 6% were discharged
before the end of the treatment. Of the 96 hospitalized
cut off Ribotype
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FIGURE 2. Dendrogram of similarities among 124 MRSA isolates,
using ribotyping. The vertical line is the cut-off below which a
difference of one band or less between isolates is observed.
patients still alive at the time of discharge, 32 (33%)
were considered culture-negative (2 consecutive neg-
ative cultures), whereas 40 patients (42%) still were
considered positive; in 24 patients (25%), the presence
of MRSA could not be assessed. Among the 40
patients who still were positive, 28 (70%) received
local and systemic antibiotics and 12 (30%) received
no treatment. This was significantly different from the
32 patients who became negative and among whom
only three (9%) received no systemic antibiotics.
Overall, 7% of the strains were resistant to co-
trimoxazole; 33% to rifampicin. The proportions of
strains resistant to these antibiotics were similar in
patients with negative or positive control cultures after
treatment. No strain was resistant to mupirocin.
Among the 52 patients who were readmitted to
the hospital (3 days to 7 months later, median 5.7
months), 22 had positive cultures at the end of their
first stay. Out of the 19 cases who had surveillance
cultur s obtained upon readmission, 10 still were
positive. Among these 10 patients, two were found to
have epidemiological links with subsequent cases and
might have been the sources of their MRSA
Among the 80 epidemiologically related patients,
only 13 were breakthrough cases. Most of these
breakthrough cases occurred soon after the identifica-
tion of a cluster, suggesting that some of them
probably already were colonized at the time of imple-
mentation of control measures.
Th  long-term efficacy of the control measures
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FIGURE 3. Monthly incidence of patients infected with MRSA according to their ribotypes. Epidemiologic clusters of 3 cases or more are
pointed out by a black area. Patients of the dermatological and ENT unit clusters belong to ribotype 1, whereas those of the burn unit cluster
belong to ribotype 8. Arrows on the x-axis show pseudoclusters.
was estimated by the median follow-up duration after
the last positive culture for a given ribotype in the
hospital. At the end of 1992, the median follow-up
duration was 14 months (range, 1 to 42 months) for
the ribotypes involved in clusters, and 25 months
(range, 1 to 46 months) for the 17 ribotypes isolated
only from one patient. Moreover, ribotype 1, which
accounted for approximately one half of the patients
with MRSA, was observed only in three cases during
the last 12 months, whereas it was observed in 12
unrelated wards and in 65 cases during the first 3
years of the study. The other 8 ribotypes involved in
clusters were much more limited in time and space.
Hospital Staff
Surveillance cultures performed during clusters
among the staff in contact with patients (701 samples
in 489 individuals) identified only four nurses colo-
nized with MRSA. Isolates from three nurses were
available for typing, and the same ribotype was
observed in these nurses and in their patient(s). All
four positive nurses became persistently negative
after nasal instillation of mupirocin for 1 week.
D I S C U S S I O N
Ribotyping of MRSA satisfied relevant criteria for
any epidemiological typing system: typability and
reproducibility were 100%. In preliminary experiments,
we evaluated a wide panel of restrictive enzymes and
chose the 3 enzymes that gave the highest number of
types. Combining the results of the 3 enzymes, 32
different ribotypes were obtained, whereas the great-
est number of different ribotypes obtained with the
use of a single enzyme was only 23. Thus, combining
the results of 3 RE clearly enhanced the discrimina-
tory power of the method. It appears to be a valuable
approach for improving the performance of the typing
method.
With the use of this method and of classic
epidemiological investigation, the present study dis-
closed several interesting features of endemic and
epid mic MRSA. Over a 4-year period, 26 different
ribotypes, often represented by only one strain, were
identified in 122 patients, suggesting that new strains
were introduced regularly into the hospital from
outside sources. Moreover, among the patients who
https://doi.org/10.2307/30143091
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 13:45:53, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
Vol. 16 No. 5 MOLECULAR EPIDEMIOLOGY OF MRSA 265
were considered to have acquired their MRSA in the
community (20%) one third had not been hospitalized
in an acute or chronic care facility, suggesting that
MRSA circulating in the community may be a signifi-
cant source of MRSA for hospitals.
Little is known of the epidemiology of MRSA
within the community. In a recent study, community-
acquired cases admitted directly from their own home
represented 60% of all MRSA cases, but 88% of these
patients had at least one admission in the same
hospital within the previous 12 months.4 Epidemics in
the community have been described in some particu-
lar populations such as drug addicts2023 and chil-
dren.24 It also has been shown that discharged patients
still carrying MRSA may spread it further in the
community.25 Transmission in the community also
has been postulated to explain certain epidemic pat-
terns observed in hospitals, such as simultaneous
occurrence of cases in different wards without obvious
hospital epidemiological link.2
The diversity of strains observed in the present
study, as well as in other recent studies,4*5 and the fact
that a substantial proportion of community-acquired
cases had never been hospitalized, suggest that asymp
tomatic carriers in the community (other than IV drug
users) may constitute a significant reservoir of MRSA
for hospitals. However, it is of interest that in our study,
only two readmitted patients colonized with MRSA
were suspected to have spread their MRSA to other
patients. This possibly was due to the application of
early control measures. In the present study, only 4 of
the 489 investigated staff members were found to
harbor MRSA, of which 3 isolates could be typed.
Although the nurses shared the same ribotypes as their
patients, the direction of transmission could not be
determined. In the meantime, the low number of
positive staff members suggests that chronic carriage
by the staff was not a main source of MRSA in our
setting.
Ribotyping also proved to be a useful comple-
ment to traditional epidemiological investigations.
Indeed, several unsuspected clusters were discov-
ered, which helped us in focusing appropriate control
and educational interventions. Others also observed
that detection of small outbreaks by using a typing
method permitted concentration of infection control
efforts.4 In the same way, ribotyping allowed us to
exclude the existence of epidemic clusters that could
have been suspected on the basis of an increase of
MRSA incidence, thus avoiding unnecessary epidemi-
ological investigations.
Many studies have investigated the short-term
efficacy of infection control measures in the control of
outbreaks.2c28 In some studies, cohorting and isola-
tion alone was shown to be effective in controlling
epidemics, but not in eradicating the epidemic strain
from the hospita1.2gv30 In other studies, only the
combination of isolation, extended screening, and
mup rocin treatment of carriers31 or systemic treat-
ment32*33 was able to contain epidemics. In a long-term
prospective study, combined measures were able to
terminate several epidemics, to control undetected
clusters, and to limit nosocomial transmission. More-
over, this program was found to be cost-effective.33
Only one study assessed the efficacy of control
measures over a long period of time and with the aid
of molecular typing.4 In the present study, standard-
ized control measures were applied during the 4-year
period. The number of MRSA isolated in our hospital
remained essentially unchanged over these years.
Although the contribution of the control measures
in limiting the spread of MRSA is difficult to assess, the
use f ribotyping allowed several interesting observa-
tions. First, 17 of 26 ribotypes were found only once,
with a median follow up of 25 months. Second, break-
through cases accounted for only 16% of the cases
observed in clusters. Third, most of the clusters due to
a giv n ribotype were limited in time, with a median
follow u  after the occurrence of the last case of 14
months. Fourth, during clusters, there was a clear
temporal association between initiation of control meas-
ures and the decrease in the number of new cases.
It can be argued that these observations are not
related to the control measures that were implanted.
Indeed, some authors pointed out that the incidence
of MRSA infections may tend to rise and fall without
any apparent relationship to control measures.34 For
this reason, criteria were proposed to validate obser-
v tions on the effectiveness of a strategy for MRSA
control (baseline rate of MRSA, mode of transmission,
number of interventions, etc.). Most of these criteria
were fulfilled in the present study, suggesting that the
limitation of the spread of MRSA in our hospital was at
least partly due to the infection control program.
Clearly, further studies are needed to assess the
efficacy and cost-effectiveness of each individual con-
trol measure. Indeed, our program could be consid-
ered excessive and costly. However, in a hospital with
a low incidence of MRSA, the absolute cost of a
comprehensive program is limited, and we have
elec ed to maintain this program while awaiting fur-
ther data on the efficacy of control measures.
An important limitation of control measures is
th t MRSA cases often were discovered when they
alr ady had caused spread to other patients. Thus, in
our study, 80% of the cases were considered hospital-
acquired, but most arose before the implementation of
contr l measures. Screening on admission could be
applied to certain categories of patients (eg, patients
previously known to harbor MRSA or transferred
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from other institutions or from countries with high
MRSA prevalence). In our setting, this strategy would
be of limited efficacy, since new ribotypes were
introduced, often identified in patients who did not fall
in the above categories.
It is of note that local and systemic antimicrobial
treatment was ineffective in eradicating MRSA in a
substantial proportion of patients. Better results were
obtained in other studies that used mupirocin alone,31
with no obvious reasons for this difference. This
suggests that barrier precautions were the most
important contributor to the control of the spread of
MRSA. However, even if the bacteria were not eradi-
cated in many patients, antimicrobials may have
decreased the load of bacteria.
In the present study, there were relatively more
patients who did not receive systemic antibiotic treat-
ment among those who still had positive culture after
therapy, suggesting that local and systemic antibiotics
might be more effective than local antibiotic alone.
However, this effect was marginal and would require
further investigation. Indeed, additional interventional
studies using molecular typing are needed to better
delimit the usefulness of each control measure in
controlling the spread of endemic MRSA.
In conclusion, this study suggests that new
strains of MRSA were introduced continuously in our
hospital and that despite this constant external pres-
sure, the control measures were effective in limiting
the spread of MRSA.
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CDC Reports TB Transmission Between Passengers and Flight Crew on
Commercial Aircraft
by Gina Pugliese, RN, MS
Medical News Editor
The Centers for Disease Con-
trol and Prevention (CDC) recently
investigated six instances in which
passengers or flight crew traveled on
commercial aircraft with symptomatic,
AFB smear-positive cavitary tubercu-
losis (TB). In two instances, Myco-
bacterium tuberculosis isolated from
the index patient was resistant to
isoniazid and rifampin. Further, in two
instances, the index patients were
aware of their TB at the time of travel
and were on an international flight in
transit to the United States to obtain
medical care.
More than 2,000 passengers and
flight crew potentially were exposed
during these incidents. Follow-up
investigation can be difficult because
the airlines do not keep addresses of
passengers unless they are part of
frequent flyer programs.
The CDC concluded that trans-
mission did occur in two of the six
investigations, from flight attendant to
other flight crew and from passenger
to passenger. The cases (tuberculin
skin-test conversions) involving flight
attendants were associated with cumu-
lative flight time exposure (>12 hours)
to an infected flight attendant. All cases
involving passengers occurred in pas-
sengers seated in the same section of
the aircraft as the index passenger,
suggesting that transmission was asso-
ciated with proximity of seating.
The risk for TB transmission on
n aircraft does not appear to be
greater than in other confined spaces.
B sed on current evidence indicating a
low risk for transmission of TB on
ircraft, the CDC recommends that
the need for notification of passengers
be guided by three criteria: first,
wh ther the person with TB was infec-
tious at the time of the flight; second,
whether exposure was prolonged (eg,
the duration of the flight exceeded 8
hours); third, priority should be given
to notifying passengers and flight crew
at greatest risk for exposure, based on
proximity to the index case (for exam-
ple, depending on the aircraft design,
proximity may be defined as seating or
working in the same cabin section as
the infected passenger or crew mem-
ber).
To prevent exposures to TB
aboard an aircraft, the CDC recom-
m nds that persons known to have
infectious TB should travel by private
transportation, not commercial aircraft
or other commercial carrier. At a mini-
mum, patients with infectious TB
should be sputum smear-negative for
AFB before being placed in indoor
environments conducive to transmis-
sion.
FROM: Centers for Disease Con-
trol and Prevention. Exposure of
passengers and flight crew to Myco-
bacterium tuberculosis on commercial
aircraft, 1992-1995. MMWR.
1995;44(8):137-140.
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